LPL Financial’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
LPL Financial's MRNA Position: Q3 2026 in Review
LPL Financial increased its Moderna (MRNA) stake by 156% in Q3 2026, buying an estimated $27.3M and bringing the position to 415,283 shares worth $80M. The position accounts for 0.02% of the portfolio, ranked #791.
LPL Financial first reported a position in MRNA in Q1 2020 and has held it in 27 quarters since. 1,045 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- LPL Financial held 415,283 shares of Moderna worth $80M as of Q3 2026.
- LPL Financial bought 252,905 Moderna shares in Q3 2026, an estimated $27.3M.
- Moderna made up 0.02% of LPL Financial's portfolio in Q3 2026, its #791 holding.
- LPL Financial first reported a position in Moderna in Q1 2020 and has held it in 27 quarters since.
- 1,045 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.